Results

Total Results: 1,571 records

Showing results for "discussed".

301. Disposition of Comments_Blood-Based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-disposition-comments.pdf
     May 14, 2025 - We have discussed both MCSTs selected for the Vanguard trial in Table 1 and have added additional information … We believe that we have appropriately and thoroughly discussed the strengths and limitations of each

302. Quantitative Synthesis: Chapter 1. Decision To Combine Trials (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-1.pdf
     July 01, 2019 - the variations in the population, intervention and study factors.2,3 ► Statistical heterogeneity is discussed

303. Comparative Effectiveness Review Disposition of Comments Report: Anxiety in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
     August 31, 2017 - As discussed in later sections of our review, the subgroup analyses were quite weak and did not appear … As discussed previously, there is a serious mismatch between the ambitious aims of the report in the

304. Disposition of Comments Report for Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
     September 15, 2014 - For some specific studies some key aspects are not well- described or are not discussed in the text … description of this study to show this unusual finding. 60 Peer Reviewer 2 Results Page 163, As discussed … the original 2009 report. 117 Public comment: John Aloia Line 337 Line 337: The cost should be discussed

305. Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
     December 20, 2018 - Selected PROs were discussed in the text, and the remainder are found in the tables. … Comment Response Peer Reviewer #1 Discussion Limitations: Some weakness of the NWMA were well discussed … P88: Patient discontinuation rates varied significantly across the RCTs and observational studies discussed … Reasons for this variation and how it may impact on the applicability of the results should be discussed … Section Comment Response missing even more trials as there might have been cases where authors had discussed

306. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
     September 01, 2011 - specifically in the field of transcranial magnetic stimulation (TMS), is ongoing and the publications discussed

307. CER 216 Disposition of Comments Report: Telehealth for Acute and Chronic Care Consultations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-216-telehealth-disposition-comments.pdf
     April 24, 2019 - CER 216 Disposition of Comments Report: Telehealth for Acute and Chronic Care Consultations Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Telehealth for Acute and Chronic Care Consultations Draft review available for public comment from May 29, 2018 to June 26, 2018. Res…

308. Ch 11-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
     January 03, 2012 - on study results, as well as quasi- experimental methods to account for unmeasured confounding, are discussed … Statistical Software–Based Analysis For some of the approaches discussed, the software is available … As discussed, the strength of a confounder depends on its association with the exposure, the outcome … Using the standard spreadsheet discussed earlier,20 these conditions can be represented as a plot.

309. GRADING THE STRENGTH OF A BODY OF EVIDENCE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-strength_methods.pdf
     July 01, 2009 - None of the authors has a financial interest in any of the products discussed in this document. … These four domains are discussed in more detail below. … using statistical tests and measures of heterogeneity (such as Cochran’s Q test or I2 statistics, as discussed … The domains discussed above are directly relevant to studies of most drugs.

310. Disposition of Comments for CER 163 Appropriate Antibiotics (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
     January 27, 2016 - So the heavily contextual nature of this approach should be similarly discussed in the strengths and … not be grouped with others because of the variability of component combinations and had to be discussed … peer review consensus about the challenges of measuring resistance and appropriate prescribing (discussed … Perhaps this should be discussed, with a set of options.

311. Project Name: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
     October 25, 2011 - effects model. 1 P15 ln 40 Exec summary KQ1 – describe Type III and IV monitors before these are discussed … The key questions are appropriate and well formulated We have discussed this with our Task Order Officer … the full report (page 15, near bottom, Chapter 4 page 131): Of note, where interventions are not discussed … Numerous theoretical and research issues are also discussed that help the reader to carefully interpret … Limitations of the included studies are discussed in a thoughtful and objective manner.

312. Disposition of Comments Report for Assessment and Management of Chronic Cough (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
     January 07, 2013 - Disposition of Comments Report for Assessment and Management of Chronic Cough Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1371 Published Online: January 7, 2013 Comparative Effectiveness Research Review Disposition of Comments Repor…

313. SRDR-Charter-140305 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
     June 01, 2012 - − The list of potential board members will be reviewed and each potential board member will be discussed

314. Agenda: Impact of Healthcare Algorithms on Racial and Ethnic Disparities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/healthcare-algorithms-agenda-for-March-23.pdf
     May 29, 2025 - Agenda: Impact of Healthcare Algorithms on Racial and Ethnic Disparities 1 IMPACT OF HEALTHCARE ALGORITHMS ON RACIAL AND ETHNIC DISPARITIES IN HEALTH AND HEALTHCARE AGENDA March 2–3, 2023 National Institutes of Health (NIH) Natcher Conference Center 45 Center Drive, Building 45, Bethesda, MD 20892 …

315. Disposition of Comments for CER 212 Nonsurgical Treatments for Urinary Incontinence in Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-212-urinary-incontinence-disposition-comments.pdf
     August 08, 2018 - Furthermore, assumptions and limitations need to be discussed for the specific methods implemented … Thank you Methods Peer Reviewer #3 I prefer to see definitions of 'meaningful clinical differences' discussed … For instance, in neither the exec summary or the report itself is this issue discussed. … We have, however, more clearly discussed the evidence pertinent to the specific populations, as subanalyses … Limiting the review to non surgical treatments is a fair limitation of scope, as most of the techniques discussed

316. Proposed Governance and Data Management Policy for the Systematic Review Data Repository (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/data-repository-reviews_white-paper.pdf
     September 01, 2012 - including the specifics of the functioning, role and responsibilities of the governing body would be discussed … developed in partnership with the governing body. 8 Conclusion Herein, we have discussed

317. Back (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/back.pdf
     January 01, 2011 - Back Slide  1: Decision making  when clinical evidence  is limited: Palliative  chemotherapy  for cancer Anthony Back, MD University of Washington Fred  Hutchinson Cancer Research Center Seattle, Washington Slide  2: The  problem • 33 yo  man …

318. Disposition of Comments for Screening for Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_disposition-comments.pdf
     April 01, 2012 - of the question (for example visual impairment in Key Question 1) We understand that all outcomes discussed … We will reemphasize in the discussion, as discussed in the body of the report (Burr 2007), that "that … candidate tests, we chose not to include such a display in the report as among the included studies discussed

319. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/module_iii2.ppt
     May 29, 2025 - Slide 1 Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators Numeric

320. Disposition of Comments for Psychological Treatments and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
     April 03, 2013 - We have discussed this with our team and with experts in the field and have decided to categorize … These two studies were ones that we have discussed with our full team. … We have carefully considered this suggestion and discussed it with our research team.